Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin E: more than an antioxidant

M Steiner1

  • 1Division of Hematology, Brown University, Providence, Rhode Island.

Clinical Cardiology
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Vitamin E inhibits platelet aggregation in lab tests but not in the body. However, alpha-tocopherol (vitamin E) significantly reduces platelet adhesion in vivo, potentially preventing blood clots.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Decline of caries prevalence in Swiss military recruits between 1970 and 1996].

Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia·2001
Same author

The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.

CNS drug reviews·2001
Same author

The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder.

BJOG : an international journal of obstetrics and gynaecology·2001
Same author

Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer.

Anticancer research·2001
Same author

Aged garlic extract, a modulator of cardiovascular risk factors: a dose-finding study on the effects of AGE on platelet functions.

The Journal of nutrition·2001
Same author

Diagnosis and treatment of premenstrual dysphoric disorder: an update.

International clinical psychopharmacology·2001
Same journal

Comparing Ferric Carboxymaltose Versus Iron Sucrose in Patients with Heart Failure.

Clinical cardiology·2026
Same journal

Beyond Rural Versus Urban: Referral Pathways and Structural Heart Programs May Influence Outcomes After Left Atrial Appendage Occlusion.

Clinical cardiology·2026
Same journal

Strauss-Defined LBBB Identifies Patients With Improved Outcomes After CRT-D: A Comparative Cohort Study.

Clinical cardiology·2026
Same journal

Does Serum γKlotho Truly Provide Incremental Prognostic Value Beyond Established Risk Predictors in Multivessel Coronary Artery Disease?

Clinical cardiology·2026
Same journal

Associations of the C-Reactive Protein-Albumin-Lymphocyte Index, Red Cell Distribution Width-Albumin Ratio, and Blood Urea Nitrogen-Albumin Ratio With All-Cause and Cardiovascular Mortality Among Adults With Preclinical Heart Failure.

Clinical cardiology·2026
Same journal

Real-World National Databases Versus Hypothesis-Driven Cohort Studies: A Reply to the Critique on the TURK-HF Registry Design.

Clinical cardiology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Hematology
  • Nutrition Science

Background:

  • Vitamin E is a lipid-soluble antioxidant with known effects on cell membranes.
  • Platelet function is crucial in hemostasis and thrombosis.
  • Previous research suggests vitamin E may influence platelet activity.

Purpose of the Study:

  • To review the effects of vitamin E on platelet aggregation and adhesion.
  • To elucidate the in vivo and in vitro mechanisms of vitamin E's impact on platelets.
  • To assess the potential of vitamin E as a therapeutic agent for thromboembolic diseases.

Main Methods:

  • In vitro and in vivo studies examining platelet aggregation.
  • Assessment of platelet adhesion using a laminar flow chamber with various adhesive proteins.

Related Experiment Videos

  • Analysis of platelet morphology and pseudopodia formation.
  • Investigation of potential molecular mechanisms, including fatty acylation.

    • Main Results:

    • Vitamin E demonstrated significant inhibition of platelet aggregation in vitro.
    • In vivo administration of vitamin E (up to 1200 U/day) showed no significant effect on platelet aggregation.
    • Alpha-tocopherol strongly inhibited platelet adhesion in vivo, with 400 IU/day yielding >75% inhibition.
    • The antiadhesive effect is linked to reduced pseudopodia formation and potential alterations in protein fatty acylation.

    Conclusions:

    • Vitamin E's primary effect on platelet function in vivo is the inhibition of adhesion, not aggregation.
    • Alpha-tocopherol's antiadhesive properties may offer a therapeutic benefit in preventing thromboembolic events.
    • Further clinical studies are warranted to confirm the efficacy of vitamin E supplementation in patients with thromboembolic disease.